Study finds NSAID allergies among stroke patients are mislabeled in 80% of cases

A recent study conducted by the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) found that mislabeled NSAID (Non-Steroidal Anti-Inflammatory Drug) allergies for stroke patients hinders the use of effective medications for them, leading to poorer treatment outcomes. It also revealed that when stroke survivors with NSAID allergy labels underwent testing, 80% were found to be mislabeled.